Crystal Structure of Caspase-2, Apical Initiator of the Intrinsic Apoptotic Pathway*

The cell death protease caspase-2 has recently been recognized as the most apical caspase in the apoptotic cascade ignited during cell stress signaling. Cytotoxic stress, such as that caused by cancer therapies, leads to activation of caspase-2, which acts as a direct effector of the mitochondrion-dependent apoptotic pathway resulting in programmed cell death. Here we report the x-ray structure of caspase-2 in complex with the inhibitor acetyl-Leu-Asp-Glu-Ser-Asp-aldehyde at 1.65-Å resolution. Compared with other caspases, significant structural differences prevail in the active site region and the dimer interface. The structure reveals the hydrophobic properties of the S5 specificity pocket, which is unique to caspase-2, and provides the details of the inhibitor-protein interactions in subsites S1-S4. These features form the basis of caspase-2 specificity and allow the design of caspase-2-directed ligands for medical and analytical use. Another unique feature of caspase-2 is a disulfide bridge at the dimer interface, which covalently links the two monomers. Consistent with this finding, caspase-2 exists as a (p19/p12)2 dimer in solution, even in the absence of substrates or inhibitors. The intersubunit disulfide bridge stabilizes the dimeric form of caspase-2, whereas all other long prodomain caspases exist as monomers in solution, and dimer formation is driven by ligand binding. Therefore, the central disulfide bridge appears to represent a novel way of dimer stabilization in caspases.

[1]  A. Hackam,et al.  Kennedy's Disease , 1999, Journal of neurochemistry.

[2]  S. Murota,et al.  A caspase inhibitor blocks ischaemia‐induced delayed neuronal death in the gerbil , 1998, The European journal of neuroscience.

[3]  Mark A. Murcko,et al.  Structure and mechanism of interleukin-lβ converting enzyme , 1994, Nature.

[4]  Ximena Opitz-Araya,et al.  Requirement for Caspase-2 in Stress-Induced Apoptosis Before Mitochondrial Permeabilization , 2002, Science.

[5]  K. Wilson,et al.  The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. , 2000, Chemistry & biology.

[6]  M. Grütter,et al.  Structure of Recombinant Human CPP32 in Complex with the Tetrapeptide Acetyl-Asp-Val-Ala-Asp Fluoromethyl Ketone* , 1997, The Journal of Biological Chemistry.

[7]  M. Grütter,et al.  Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex. , 2000, Journal of molecular biology.

[8]  C. Thompson,et al.  The central effectors of cell death in the immune system. , 1999, Annual review of immunology.

[9]  R. Zamboni,et al.  Purification and catalytic properties of human caspase family members , 1999, Cell Death and Differentiation.

[10]  H. Steller Mechanisms and genes of cellular suicide , 1995, Science.

[11]  M. Grütter,et al.  The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. , 1999, Structure.

[12]  C. Briand,et al.  Insights into the regulatory mechanism for caspase-8 activation. , 2003, Molecular cell.

[13]  N. Thornberry,et al.  Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors* , 1998, The Journal of Biological Chemistry.

[14]  M. Moskowitz,et al.  Defects in regulation of apoptosis in caspase-2-deficient mice. , 1998, Genes & development.

[15]  CM Troy,et al.  Caspase-2 redux , 2003, Cell Death and Differentiation.

[16]  Sten Orrenius,et al.  Caspase-2 Acts Upstream of Mitochondria to Promote Cytochromec Release during Etoposide-induced Apoptosis* , 2002, The Journal of Biological Chemistry.

[17]  J. Mankovich,et al.  Substrate Specificities of Caspase Family Proteases* , 1997, The Journal of Biological Chemistry.

[18]  N. Thornberry,et al.  The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis , 1996, Nature Structural Biology.

[19]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[20]  R. Liddington,et al.  Dimer formation drives the activation of the cell death protease caspase 9 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Auberger,et al.  A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  C. Croce,et al.  Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. , 2003, Cancer research.

[23]  L. Wang,et al.  Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death , 1994, Cell.

[24]  G. Salvesen,et al.  Caspases: preparation and characterization. , 1999, Methods.

[25]  P. Thall,et al.  Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  Gerold Wefer,et al.  Correlated Millennial-Scale Changes in Surface Hydrography and Terrigenous Sediment Yield Inferred from Last-Glacial Marine Deposits off Northeastern Brazil , 1998, Quaternary Research.

[27]  J. Mankovich,et al.  Stability and Oligomeric Equilibria of Refolded Interleukin-1β Converting Enzyme* , 1996, The Journal of Biological Chemistry.

[28]  R. Oppenheim,et al.  Peptide inhibitors of the ice protease family arrest programmed cell death of motoneurons in vivo and in vitro , 1995, Neuron.

[29]  J. Mankovich,et al.  Crystal structure of the cysteine protease interleukin-1β-converting enzyme: A (p20/p10)2 homodimer , 1994, Cell.

[30]  P. Vandenabeele,et al.  Alice in caspase land. A phylogenetic analysis of caspases from worm to man , 2002, Cell Death and Differentiation.

[31]  N. Thornberry,et al.  A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.

[32]  H. Horvitz,et al.  Mechanisms and functions of cell death. , 1991, Annual review of cell biology.

[33]  Vishva M. Dixit,et al.  RAIDD is a new 'death' adaptor molecule , 1997, Nature.

[34]  S. Kumar,et al.  Apaf-1/cytochrome c apoptosome: an essential initiatorof caspase activation or just a sideshow? , 2003, Cell Death and Differentiation.

[35]  D. Vaux,et al.  A novel Apaf-1–independent putative caspase-2 activation complex , 2002, The Journal of cell biology.

[36]  S. Srinivasula,et al.  Caspase-2 Induces Apoptosis by Releasing Proapoptotic Proteins from Mitochondria* , 2002, The Journal of Biological Chemistry.

[37]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[38]  A. Tomasselli,et al.  The atomic-resolution structure of human caspase-8, a key activator of apoptosis. , 1999, Structure.

[39]  Keisuke Kuida,et al.  Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome , 2002, Nature.

[40]  R. Tanzi,et al.  Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. , 1997, Science.

[41]  D. Vaux,et al.  A Cinderella Caspase Takes Center Stage , 2002, Science.

[42]  D. Green,et al.  A unified model for apical caspase activation. , 2003, Molecular cell.

[43]  S. Srinivasula,et al.  Oligomerization Is a General Mechanism for the Activation of Apoptosis Initiator and Inflammatory Procaspases* , 2003, The Journal of Biological Chemistry.

[44]  N. Thornberry,et al.  Caspases: killer proteases. , 1997, Trends in biochemical sciences.

[45]  J. Cleveland,et al.  Neuroprotection by a caspase inhibitor in acute bacterial meningitis , 1999, Nature Medicine.